Professor Kittiyod Poovorawan
Contact information
Research groups
Kittiyod Poovorawan
Associate Professor and Research Physician
An Associate Professor in the Department of Clinical Tropical Medicine, Faculty of Tropical Medicine (FTM) at Mahidol University in Bangkok, Kittiyod Poovorawan has been a member of MORU’s Clinical Therapeutics Unit (CTU) since 2019.
A Thai medical doctor board-certified in internal medicine and gastroenterology, Kittiyod has expertise in internal medicine, gastroenterology, hepatology, and clinical research of tropical diseases.
Kittiyod specialises in both teaching and clinical research. He teaches students from the Diploma, MSc, and PhD courses at the Bangkok School of Tropical Medicine, works as a gastroenterology consultant physician, and is the deputy director of the Hospital for Tropical Diseases in Bangkok.
Kittiyod’s primary research area is liver diseases including viral hepatitis, liver abscess, chronic liver disease, and gastrointestinal involvement in tropical diseases. He is experienced in conducting clinical trials on viral hepatitis and tropical infectious diseases. He is a part of an active clinical research team, conducting several research projects including pharmacological studies of antimalarial, platform studies in COVID-19, and The Malaria Infection Study in Thailand (MIST).
Kittiyod has published more than 60 international peer-reviewed research articles and his current and future research focusses on tropical infectious diseases and viral hepatitis elimination.
Recent publications
-
Characteristics of Drug-induced Liver Injury in Chronic Liver Disease: Results from the Thai Association for the Study of the Liver (THASL) DILI Registry.
Journal article
Chirapongsathorn S. et al, (2023), Journal of clinical and translational hepatology, 11, 88 - 96
-
Severity of COVID-19 in Patients with Diarrhoea: A Systematic Review and Meta-Analysis.
Journal article
Dhakal S. et al, (2023), Trop Med Infect Dis, 8
-
Prevalence, Risk Factors, and Prognosis of Liver Involvement in Adult Patients with Chikungunya in Thailand.
Journal article
Srikirin P. et al, (2022), The American journal of tropical medicine and hygiene
-
Safety, pharmacokinetics, and antiviral activity of the capsid inhibitor AB-506 from Phase 1 studies in healthy subjects and those with hepatitis B.
Journal article
Yuen M-F. et al, (2022), Hepatology communications
-
Genetic variation in STAT4 is associated with treatment response to pegylated interferon in patients with chronic hepatitis B.
Journal article
Limothai U. et al, (2022), Asian Pacific journal of allergy and immunology, 40, 87 - 93